docetaxel,pembrolizumab
merck
['biomarker', 'breast', 'neopact', 'tnbc']
the next #asco23 session begins at 11:30, stop by hall b1 and check out differential impact of proliferation signature on efficacy of neoadjuvant chemoimmunotherapy in stil-high and stil-low triple-negative breast cancer: biomarker analysis of the neopact trial. #tnbc 
We are transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our patient care program